{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:17:48Z","timestamp":1792012668640,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00392-018-1215-5","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T08:06:49Z","timestamp":1518682009000},"page":"548-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany"],"prefix":"10.1007","volume":"107","author":[{"given":"Thorsten","family":"Kramm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrike","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph B.","family":"Wiedenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Weingard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doerte","family":"Huscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pittrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serghei","family":"Cebotari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9086-2293","authenticated-orcid":false,"given":"Marius M.","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"issue":"6","key":"1215_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.114.009309","volume":"130","author":"IM Lang","year":"2014","unstructured":"Lang IM, Madani M (2014) Update on chronic thromboembolic pulmonary hypertension. Circulation 130(6):508\u2013518. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009309","journal-title":"Circulation"},{"issue":"7","key":"1215_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S2213-2600(14)70089-X","volume":"2","author":"MM Hoeper","year":"2014","unstructured":"Hoeper MM, Madani MM, Nakanishi N, Meyer B, Cebotari S, Rubin LJ (2014) Chronic thromboembolic pulmonary hypertension. Lancet Respir Med 2(7):573\u2013582. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(14)70089-X","journal-title":"Lancet Respir Med"},{"issue":"3","key":"1215_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1183\/09031936.00058112","volume":"41","author":"DP Jenkins","year":"2013","unstructured":"Jenkins DP, Madani M, Mayer E, Kerr K, Kim N, Klepetko W, Morsolini M, Dartevelle P (2013) Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 41(3):735\u2013742. \n                    https:\/\/doi.org\/10.1183\/09031936.00058112","journal-title":"Eur Respir J"},{"issue":"3","key":"1215_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","volume":"141","author":"E Mayer","year":"2011","unstructured":"Mayer E, Jenkins D, Lindner J, D\u2019Armini A, Kloek J, Meyns B, Ilkjaer LB, Klepetko W, Delcroix M, Lang I, Pepke-Zaba J, Simonneau G, Dartevelle P (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 141(3):702\u2013710. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2010.11.024","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"1215_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","volume":"94","author":"MM Madani","year":"2012","unstructured":"Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, Fedullo PF, Jamieson SW (2012) Pulmonary endarterectomy: recent changes in a single institution\u2019s experience of more than 2,700 patients. Ann Thorac Surg 94(1):97\u2013103. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2012.04.004\n                    \n                   (discussion 103)","journal-title":"Ann Thorac Surg"},{"issue":"18","key":"1215_CR6","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.115.019470","volume":"133","author":"JE Cannon","year":"2016","unstructured":"Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, Treacy C, Ponnaberanam A, Condliffe R, Sheares K, Taboada D, Dunning J, Tsui S, Ng C, Gopalan D, Screaton N, Elliot C, Gibbs S, Howard L, Corris P, Lordan J, Johnson M, Peacock A, MacKenzie-Ross R, Schreiber B, Coghlan G, Dimopoulos K, Wort SJ, Gaine S, Moledina S, Jenkins DP, Pepke-Zaba J (2016) Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort. Circulation 133(18):1761\u20131771. \n                    https:\/\/doi.org\/10.1161\/circulationaha.115.019470","journal-title":"Circulation"},{"issue":"4","key":"1215_CR7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1183\/09031936.00201612","volume":"41","author":"J Pepke-Zaba","year":"2013","unstructured":"Pepke-Zaba J, Jansa P, Kim NH, Naeije R, Simonneau G (2013) Chronic thromboembolic pulmonary hypertension: role of medical therapy. Eur Respir J 41(4):985\u2013990. \n                    https:\/\/doi.org\/10.1183\/09031936.00201612","journal-title":"Eur Respir J"},{"issue":"5","key":"1215_CR8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1183\/09031936.00012914","volume":"43","author":"S Fukui","year":"2014","unstructured":"Fukui S, Ogo T, Morita Y, Tsuji A, Tateishi E, Ozaki K, Sanda Y, Fukuda T, Yasuda S, Ogawa H, Nakanishi N (2014) Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 43(5):1394\u20131402. \n                    https:\/\/doi.org\/10.1183\/09031936.00012914","journal-title":"Eur Respir J"},{"issue":"5","key":"1215_CR9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1183\/09031936.00037114","volume":"43","author":"MM Hoeper","year":"2014","unstructured":"Hoeper MM (2014) Chronic thromboembolic pulmonary hypertension at the crossroad. Eur Respir J 43(5):1230\u20131232. \n                    https:\/\/doi.org\/10.1183\/09031936.00037114","journal-title":"Eur Respir J"},{"issue":"10","key":"1215_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S2213-2600(17)30305-3","volume":"5","author":"HA Ghofrani","year":"2017","unstructured":"Ghofrani HA, Simonneau G, D\u2019Armini AM, Fedullo P, Howard LS, Jais X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH, Investigators Ms (2017) Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir Med 5(10):785\u2013794. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(17)30305-3","journal-title":"Lancet Respir Med"},{"issue":"3","key":"1215_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00392-016-1037-2","volume":"106","author":"MJ Richter","year":"2017","unstructured":"Richter MJ, Ewert R, Warnke C, Gall H, Classen S, Grimminger F, Mayer E, Seeger W, Ghofrani HA (2017) Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension. Clin Res Cardiol 106(3):174\u2013182. \n                    https:\/\/doi.org\/10.1007\/s00392-016-1037-2","journal-title":"Clin Res Cardiol"},{"issue":"23 Suppl 1","key":"1215_CR12","doi-asserted-by":"publisher","first-page":"I4","DOI":"10.1161\/01.cir.0000078468.11849.66","volume":"107","author":"RH White","year":"2003","unstructured":"White RH (2003) The epidemiology of venous thromboembolism. Circulation 107(23 Suppl 1):I4\u2013I8. \n                    https:\/\/doi.org\/10.1161\/01.cir.0000078468.11849.66","journal-title":"Circulation"},{"issue":"8","key":"1215_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jacc.2015.11.061","volume":"67","author":"SV Konstantinides","year":"2016","unstructured":"Konstantinides SV, Barco S, Lankeit M, Meyer G (2016) Management of pulmonary embolism: an update. J Am Coll Cardiol 67(8):976\u2013990. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.11.061","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1215_CR14","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","volume":"34","author":"GE Raskob","year":"2014","unstructured":"Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI (2014) Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34(11):2363\u20132371. \n                    https:\/\/doi.org\/10.1161\/atvbaha.114.304488","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1215_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.thromres.2009.01.003","volume":"124","author":"F Dentali","year":"2009","unstructured":"Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, Ageno W (2009) Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 124(3):256\u2013258. \n                    https:\/\/doi.org\/10.1016\/j.thromres.2009.01.003","journal-title":"Thromb Res"},{"issue":"1","key":"1215_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1378\/chest.130.1.172","volume":"130","author":"C Becattini","year":"2006","unstructured":"Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 130(1):172\u2013175","journal-title":"Chest"},{"issue":"22","key":"1215_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa032274","volume":"350","author":"V Pengo","year":"2004","unstructured":"Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350(22):2257\u20132264","journal-title":"N Engl J Med"},{"issue":"10","key":"1215_CR18","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1161\/01.CIR.99.10.1325","volume":"99","author":"A Ribeiro","year":"1999","unstructured":"Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L (1999) Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 99(10):1325\u20131330","journal-title":"Circulation"},{"key":"1215_CR19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01792-2016","author":"YM Ende-Verhaar","year":"2017","unstructured":"Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, Huisman MV, Klok FA (2017) Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. \n                    https:\/\/doi.org\/10.1183\/13993003.01792-2016","journal-title":"Eur Respir J"},{"issue":"10","key":"1215_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1164\/rccm.200712-1841OC","volume":"177","author":"R Condliffe","year":"2008","unstructured":"Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SS, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177(10):1122\u20131127. \n                    https:\/\/doi.org\/10.1164\/rccm.200712-1841OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1215_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1183\/09031936.00101211","volume":"40","author":"P Escribano-Subias","year":"2012","unstructured":"Escribano-Subias P, Blanco I, Lopez-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, Castillo-Palma MJ, Segovia J, Gomez-Sanchez MA, Barbera JA, Investigators R (2012) Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 40 (3):596\u2013603. \n                    https:\/\/doi.org\/10.1183\/09031936.00101211","journal-title":"Eur Respir J"},{"key":"1215_CR22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00740-2017","author":"MM Hoeper","year":"2017","unstructured":"Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grunig E (2017) Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. \n                    https:\/\/doi.org\/10.1183\/13993003.00740-2017","journal-title":"Eur Respir J"},{"issue":"4","key":"1215_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2015) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 46(4):903\u2013975. \n                    https:\/\/doi.org\/10.1183\/13993003.01032-2015","journal-title":"Eur Respir J"},{"key":"1215_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02522-2016","author":"G Simonneau","year":"2017","unstructured":"Simonneau G, Hoeper MM (2017) Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension. Eur Respir J. \n                    https:\/\/doi.org\/10.1183\/13993003.02522-2016","journal-title":"Eur Respir J"},{"issue":"10","key":"1215_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.114.009107","volume":"130","author":"KK Sogaard","year":"2014","unstructured":"Sogaard KK, Schmidt M, Pedersen L, Horvath-Puho E, Sorensen HT (2014) 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130(10):829\u2013836. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009107","journal-title":"Circulation"},{"issue":"18","key":"1215_CR26","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","volume":"124","author":"J Pepke-Zaba","year":"2011","unstructured":"Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D\u2019Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barbera JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jais X, Simonneau G (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124(18):1973\u20131981. \n                    https:\/\/doi.org\/10.1161\/circulationaha.110.015008","journal-title":"Circulation"},{"issue":"2","key":"1215_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jacc.2015.10.060","volume":"67","author":"D Jimenez","year":"2016","unstructured":"Jimenez D, de Miguel-Diez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, Muriel A, Meyer G, Yusen RD, Monreal M, Investigators R (2016) Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol 67(2):162\u2013170. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.10.060","journal-title":"J Am Coll Cardiol"},{"key":"1215_CR28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02409-2016","author":"KM Olsson","year":"2017","unstructured":"Olsson KM, Wiedenroth CB, Kamp JC, Breithecker A, Fuge J, Krombach GA, Haas M, Hamm C, Kramm T, Guth S, Ghofrani HA, Hinrichs JB, Cebotari S, Meyer K, Hoeper MM, Mayer E, Liebetrau C, Meyer BC (2017) Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J. \n                    https:\/\/doi.org\/10.1183\/13993003.02409-2016","journal-title":"Eur Respir J"},{"issue":"13","key":"1215_CR29","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/CIRCULATIONAHA.109.865881","volume":"120","author":"KW Jensen","year":"2009","unstructured":"Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR (2009) Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 120(13):1248\u20131254. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.865881","journal-title":"Circulation"},{"issue":"10","key":"1215_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jamainternmed.2013.319","volume":"173","author":"RC Deano","year":"2013","unstructured":"Deano RC, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin VV, Gomberg-Maitland M (2013) Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med 173(10):887\u2013893. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2013.319","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1215_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1378\/chest.11-3060","volume":"143","author":"VV McLaughlin","year":"2013","unstructured":"McLaughlin VV, Langer A, Tan M, Clements PJ, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ (2013) Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest 143(2):324\u2013332. \n                    https:\/\/doi.org\/10.1378\/chest.11-3060","journal-title":"Chest"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1215-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T20:22:13Z","timestamp":1550175733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1215-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1215-5","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T. Kramm has received speaker fees from Actelion, Bayer and GSK. H. Wilkens has received speaker fees and honoraria for consultation from Actelion, Bayer, Boehringer-Ingelheim, GSK, MSD, Pfizer and Roche. J. Fuge has nothing to disclose. HJ Sch\u00e4fers has received speaker fees from Bayer. S. Guth has received speaker fees from Actelion, Bayer, GSK and Pfizer. CB Wiedenroth has received speaker fees or consultant honoraria from Actelion, Bayer AG, BTG, MSD and Pfizer. B. Weingard has received speaker fees and consultation honoraria from Bayer. D. Huscher has received author and consultation honoraria from Actelion. D. Pittrow has received speaker fees or honoraria for consultations from Actelion, AstraZeneca, Aspen, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Novartis, Shield and Pfizer. M.M. Hoeper has received speaker fees and honoraria for consultations from Actelion, Bayer, Gilead, GSK, MSD and Pfizer. S. Cebotari has nothing to disclose. E. Mayer has received speaker and consulting fees from Actelion, Bayer, GSK, and Pfizer. KM Olsson has received speaker fees and honoraria for consultations from Actelion, Bayer, GSK, Pfizer and United Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}